Show simple item record

dc.contributor.authorTrulove, Susanen_US
dc.coverage.spatialBlacksburg, Va.en_US
dc.date.accessioned2015-10-29T21:34:02Z
dc.date.available2015-10-29T21:34:02Z
dc.date.issued2009-04-13en_US
dc.identifier.urihttp://hdl.handle.net/10919/61876
dc.description.abstractResearchers from Virginia Tech and Molsoft LLC have received a five-year, $3.557 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to continue their promising work on a new class of resistance-breaking insecticides to reduce malaria transmission.en_US
dc.format.mimetypetext/htmlen_US
dc.publisherVirginia Tech. University Relationsen_US
dc.rightsIn Copyright (InC)en_US
dc.rightsThis Item is protected by copyright and/or related rights. Some uses of this Item may be deemed fair and permitted by law even without permission from the rights holder(s). For other uses you need to obtain permission from the rights holder(s).en_US
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectCollege of Scienceen_US
dc.titleNational Institutes of Health funds development of resistance-breaking insecticides to reduce malaria transmissionen_US
dc.typePress releaseen_US
dc.rights.holderVirginia Tech. University Relationsen_US
dc.type.dcmitypeTexten_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record